Abstract:Objectives: Adipose tissue depots vary markedly in their ability to store and metabolize triglycerides, undergo beige adipogenesis and susceptibility to metabolic disease. The molecular mechanisms that underlie such heterogeneity are not entirely clear. Previously, we showed that TGF-β signaling suppresses beige adipogenesis via repressing the recruitment of dedicated beige progenitors. Here, we find that TGF-β signals dynamically regulate the balance between adipose tissue fibrosis and beige adipogenesis. Methods: We investigated adipose tissue depot-specific differences in activation of TGF-β signaling in response to dietary challenge. RNA-seq and fluorescence activated cell sorting was performed to identify and characterize cells responding to changes in TGF-β signaling status. Mouse models, pharmacological strategies and human adipose tissue analyses were performed to further define the influence of TGF-β signaling on fibrosis and functional beige adipogenesis. Results: Elevated basal and high-fat diet inducible activation of TGF-β/Smad3 signaling was observed in the visceral adipose tissue depot. Activation of TGF-β/Smad3 signaling was associated with increased adipose tissue fibrosis. RNA-seq combined with fluorescence-activated cell sorting of stromal vascular fraction of epididymal white adipose tissue depot resulted in identification of TGF-β/Smad3 regulated ITGA5+ fibrogenic progenitors. TGF-β/Smad3 signal inhibition, genetically or pharmacologically, reduced fibrosis and increased functional beige adipogenesis. TGF-β/Smad3 antagonized the beneficial effects of PPARγ whereas TGF-β receptor 1 inhibition synergized with actions of rosiglitazone, a PPARγ agonist, to dampen fibrosis and promote beige adipogenesis. Positive correlation between TGF-β activation and ITGA5 was observed in human adipose tissue, with visceral adipose tissue depots exhibiting higher fibrosis potential than subcutaneous or brown adipose tissue depots. Conclusions: Basal and high-fat diet inducible activation of TGF-β underlies the heterogeneity of adipose tissue depots. TGF-β/Smad3 activation promotes adipose tissue fibrosis and suppresses beige progenitors. Together, these dual mechanisms preclude functional beige adipogenesis. Controlled inhibition of TβRI signaling and concomitant PPARγ stimulation can suppress adipose tissue fibrosis and promote beige adipogenesis to improve metabolism.

The Hippo pathway links adipocyte plasticity to adipose tissue fibrosis

Hippo–YAP/TAZ signalling coordinates adipose plasticity and energy balance by uncoupling leptin expression from fat mass

Challenges and opportunities in obesity: the role of adipocytes during tissue fibrosis

Phosphorylation of Angiomotin by Lats1/2 Kinases Inhibits F-actin Binding, Cell Migration, and Angiogenesis

Hippo Pathway Deletion in Adult Resting Cardiac Fibroblasts Initiates a Cell State Transition with Spontaneous and Self-Sustaining Fibrosis

Abstract P1168: Hippo Signaling Interacts With Tgfb Pathway To Regulate Pacemaker Cell State And Fibrosis In The Sinoatrial Node

Molecular mechanisms of the mammalian Hippo signaling pathway.

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

Abstract IA21: the Hippo Pathway in Cancer

YAP and TAZ Protect Against White Adipocyte Cell Death During Obesity

Interrelation of adipose tissue macrophages and fibrosis in obesity

Hippo Signaling: Key Emerging Pathway in Cellular and Whole-Body Metabolism

Lats2 Modulates Adipocyte Proliferation And Differentiation Via Hippo Signaling

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

Ampk Activation By Metformin Suppresses Abnormal Extracellular Matrix Remodeling In Adipose Tissue And Ameliorates Insulin Resistance In Obesity

Autophagy inhibition blunts PDGFRA adipose progenitors' cell-autonomous fibrogenic response to high-fat diet

The role of YAP/TAZ signaling in dendritic cell-mediated pathogenesis of insulin resistance and non-alcoholic fatty liver disease

The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease

Physiological and pathological roles of the Hippo‐YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis

TGF-β antagonism synergizes with PPARγ agonism to reduce fibrosis and enhance beige adipogenesis